MDA SPACE LTD (MDA.CA) Stock Fundamental Analysis
TSX:MDA • CA55293N1096
33.59 CAD
-1.43 (-4.08%)
Last: Feb 12, 2026, 07:00 PM
MDA gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 13 industry peers in the Aerospace & Defense industry. Both the profitability and the financial health of MDA get a neutral evaluation. Nothing too spectacular is happening here. MDA is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
- In the past year MDA was profitable.
- In the past year MDA had a positive cash flow from operations.
- MDA had positive earnings in 4 of the past 5 years.
- Each year in the past 5 years MDA had a positive operating cash flow.
1.2 Ratios
- MDA's Return On Assets of 3.15% is fine compared to the rest of the industry. MDA outperforms 69.23% of its industry peers.
- Looking at the Return On Equity, with a value of 8.24%, MDA is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
- Looking at the Return On Invested Capital, with a value of 5.12%, MDA is doing worse than 61.54% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for MDA is below the industry average of 8.16%.
- The 3 year average ROIC (3.99%) for MDA is below the current ROIC(5.12%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.15% | ||
| ROE | 8.24% | ||
| ROIC | 5.12% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
1.3 Margins
- MDA has a Profit Margin of 7.40%. This is in the better half of the industry: MDA outperforms 76.92% of its industry peers.
- In the last couple of years the Profit Margin of MDA has grown nicely.
- MDA has a worse Operating Margin (9.86%) than 61.54% of its industry peers.
- MDA's Operating Margin has improved in the last couple of years.
- MDA's Gross Margin of 24.62% is fine compared to the rest of the industry. MDA outperforms 69.23% of its industry peers.
- In the last couple of years the Gross Margin of MDA has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.86% | ||
| PM (TTM) | 7.4% | ||
| GM | 24.62% |
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MDA is destroying value.
- Compared to 1 year ago, MDA has more shares outstanding
- The debt/assets ratio for MDA has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 1.62, we must say that MDA is in the distress zone and has some risk of bankruptcy.
- MDA's Altman-Z score of 1.62 is fine compared to the rest of the industry. MDA outperforms 76.92% of its industry peers.
- MDA has a debt to FCF ratio of 0.92. This is a very positive value and a sign of high solvency as it would only need 0.92 years to pay back of all of its debts.
- MDA's Debt to FCF ratio of 0.92 is amongst the best of the industry. MDA outperforms 100.00% of its industry peers.
- A Debt/Equity ratio of 0.31 indicates that MDA is not too dependend on debt financing.
- With an excellent Debt to Equity ratio value of 0.31, MDA belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 0.92 | ||
| Altman-Z | 1.62 |
ROIC/WACC0.56
WACC9.11%
2.3 Liquidity
- A Current Ratio of 0.55 indicates that MDA may have some problems paying its short term obligations.
- With a Current ratio value of 0.55, MDA is not doing good in the industry: 84.62% of the companies in the same industry are doing better.
- A Quick Ratio of 0.54 indicates that MDA may have some problems paying its short term obligations.
- MDA has a Quick ratio (0.54) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.54 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 98.25% over the past year.
- MDA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 185.75% yearly.
- The Revenue has grown by 57.77% in the past year. This is a very strong growth!
- The Revenue has been growing by 31.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)57.77%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
3.2 Future
- MDA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.72% yearly.
- MDA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.84% yearly.
EPS Next Y105.61%
EPS Next 2Y48.58%
EPS Next 3Y35.72%
EPS Next 5YN/A
Revenue Next Year52.26%
Revenue Next 2Y30.25%
Revenue Next 3Y23.84%
Revenue Next 5YN/A
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 29.73, the valuation of MDA can be described as expensive.
- MDA's Price/Earnings ratio is in line with the industry average.
- The average S&P500 Price/Earnings ratio is at 27.67. MDA is around the same levels.
- The Price/Forward Earnings ratio is 21.74, which indicates a rather expensive current valuation of MDA.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of MDA is on the same level as its industry peers.
- The average S&P500 Price/Forward Earnings ratio is at 27.69. MDA is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.73 | ||
| Fwd PE | 21.74 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, MDA is valued a bit more expensive than the industry average as 69.23% of the companies are valued more cheaply.
- Based on the Price/Free Cash Flow ratio, MDA is valued a bit cheaper than 61.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.1 | ||
| EV/EBITDA | 16.92 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- MDA has a very decent profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as MDA's earnings are expected to grow with 35.72% in the coming years.
PEG (NY)0.28
PEG (5Y)N/A
EPS Next 2Y48.58%
EPS Next 3Y35.72%
5. Dividend
5.1 Amount
- No dividends for MDA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX:MDA (2/12/2026, 7:00:00 PM)
33.59
-1.43 (-4.08%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)11-14 2025-11-14/bmo
Earnings (Next)03-05 2026-03-05/amc
Inst Owners39%
Inst Owner ChangeN/A
Ins Owners1.17%
Ins Owner ChangeN/A
Market Cap4.24B
Revenue(TTM)1.48B
Net Income(TTM)109.60M
Analysts78.46
Price Target46.98 (39.86%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.07%
Min EPS beat(2)-40.3%
Max EPS beat(2)22.16%
EPS beat(4)3
Avg EPS beat(4)5.53%
Min EPS beat(4)-40.3%
Max EPS beat(4)22.16%
EPS beat(8)6
Avg EPS beat(8)21.97%
EPS beat(12)10
Avg EPS beat(12)31.49%
EPS beat(16)13
Avg EPS beat(16)66.41%
Revenue beat(2)1
Avg Revenue beat(2)0.06%
Min Revenue beat(2)-0.24%
Max Revenue beat(2)0.35%
Revenue beat(4)3
Avg Revenue beat(4)3.66%
Min Revenue beat(4)-0.24%
Max Revenue beat(4)7.65%
Revenue beat(8)5
Avg Revenue beat(8)2.65%
Revenue beat(12)9
Avg Revenue beat(12)2.56%
Revenue beat(16)11
Avg Revenue beat(16)1.78%
PT rev (1m)15.3%
PT rev (3m)5.72%
EPS NQ rev (1m)-0.36%
EPS NQ rev (3m)0.24%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.73 | ||
| Fwd PE | 21.74 | ||
| P/S | 2.87 | ||
| P/FCF | 9.1 | ||
| P/OCF | 5.77 | ||
| P/B | 3.19 | ||
| P/tB | N/A | ||
| EV/EBITDA | 16.92 |
EPS(TTM)1.13
EY3.36%
EPS(NY)1.55
Fwd EY4.6%
FCF(TTM)3.69
FCFY10.99%
OCF(TTM)5.82
OCFY17.34%
SpS11.72
BVpS10.52
TBVpS-2.82
PEG (NY)0.28
PEG (5Y)N/A
Graham Number16.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.15% | ||
| ROE | 8.24% | ||
| ROCE | 7.1% | ||
| ROIC | 5.12% | ||
| ROICexc | 5.66% | ||
| ROICexgc | 60.4% | ||
| OM | 9.86% | ||
| PM (TTM) | 7.4% | ||
| GM | 24.62% | ||
| FCFM | 31.5% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
ROICexc(3y)4.25%
ROICexc(5y)N/A
ROICexgc(3y)14.8%
ROICexgc(5y)N/A
ROCE(3y)5.54%
ROCE(5y)N/A
ROICexgc growth 3Y59.28%
ROICexgc growth 5YN/A
ROICexc growth 3Y71.38%
ROICexc growth 5YN/A
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 0.92 | ||
| Debt/EBITDA | 1.55 | ||
| Cap/Depr | 226.87% | ||
| Cap/Sales | 18.19% | ||
| Interest Coverage | 9.36 | ||
| Cash Conversion | 277.94% | ||
| Profit Quality | 425.55% | ||
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.54 | ||
| Altman-Z | 1.62 |
F-Score6
WACC9.11%
ROIC/WACC0.56
Cap/Depr(3y)234.8%
Cap/Depr(5y)169.15%
Cap/Sales(3y)23.53%
Cap/Sales(5y)18.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y105.61%
EPS Next 2Y48.58%
EPS Next 3Y35.72%
EPS Next 5YN/A
Revenue 1Y (TTM)57.77%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
Revenue Next Year52.26%
Revenue Next 2Y30.25%
Revenue Next 3Y23.84%
Revenue Next 5YN/A
EBIT growth 1Y64.41%
EBIT growth 3Y76.57%
EBIT growth 5YN/A
EBIT Next Year182.32%
EBIT Next 3Y52.1%
EBIT Next 5YN/A
FCF growth 1Y631.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y674.42%
OCF growth 3Y124.48%
OCF growth 5YN/A
MDA SPACE LTD / MDA.CA FAQ
What is the fundamental rating for MDA stock?
ChartMill assigns a fundamental rating of 6 / 10 to MDA.CA.
Can you provide the valuation status for MDA SPACE LTD?
ChartMill assigns a valuation rating of 5 / 10 to MDA SPACE LTD (MDA.CA). This can be considered as Fairly Valued.
What is the profitability of MDA stock?
MDA SPACE LTD (MDA.CA) has a profitability rating of 6 / 10.
What is the financial health of MDA SPACE LTD (MDA.CA) stock?
The financial health rating of MDA SPACE LTD (MDA.CA) is 4 / 10.
What is the earnings growth outlook for MDA SPACE LTD?
The Earnings per Share (EPS) of MDA SPACE LTD (MDA.CA) is expected to grow by 105.61% in the next year.